Study Identifies Lung Cancer Areas of Improvement Across Asia-Pacific Region
Lung cancer prevention and treatment remains a challenge across the Asia-Pacific region, and each country has areas where they could improve, according to a study presented during the Day 2 […] Read more
Several Studies Assess the Fallout From the COVID-19 Pandemic in Patients With Lung Cancer
Kara Nyberg, PhDThe COVID-19 pandemic has undoubtedly altered patient care as countries have locked down to prevent spread of the virus and shifted resources to accommodate surging caseloads. It has also taken […] Read more
Curative-intent resections for NSCLC often fail. Approximately 20% to 40% of patients with lung cancer who undergo curative-intent resection, experience a relapse, and die within 4 years. One key factor […] Read more
Examining Value and Access in Lung Cancer Care, From Screening to Treatment
Beth Fand IncollingoAppropriate and swift diagnosis and treatment are crucial for patients with lung cancer but can be elusive for many due to cost, healthcare disparities, and other barriers. Factors such as […] Read more
IASLC Award Recognizes Importance of Cancer Care Teamwork
The IASLC awarded four cancer care teams from around the globe with one of the association’s most prestigious award—the IASLC Cancer Care Team Award (CCTA). The winning teams were announced […] Read more
As an increasing number of immunotherapy treatments find their way into the front-line treatment of solid tumors, including lung cancer, clinicians are often faced with a lack of options when […] Read more
Immunohistochemistry’s Important Role in Diagnosis of Thoracic Cancers Explained in a New Atlas
Keith M. Kerr, BSc, MB, ChB+more
The latest in the series of diagnostic Atlases has been published by the IASLC and its Pathology Committee. Following the highly successful editions on ALK, EGFR, ROS1 and PD-L1, this […] Read more
Program Trains Patient Research Advocates to be STARS
Lauren Evoy DavisWhat does it take to become a star in any setting? Passion, knowledge, and drive. When it comes to understanding the science of lung cancer, sometimes the experts are the […] Read more
Enhancing Your WCLC Experience with Twitter
Ivy Elkins, MBAEven those who are unfamiliar with social media platforms can find Twitter to be an easy way to discuss research and collaborate with colleagues. If you do not already have […] Read more
IASLC President Discusses Accomplishments, Adjustments, and The Year Ahead
Dr. Tetsuya Mitsudomi joined the Board of Directors of IASLC in 2011 and has served as its board president since 2019. IASLC awarded Dr. Mitsudomi its Mary J. Matthews Pathology/Translational […] Read more